SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, as coronavirus disease 2019 (COVID-19) pandemic, has killed more than a million people worldwide, and researchers are constantly working to develop therapeutics in the treatment and prevention of this new viral infection. To inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Bharadwaj, Shiv, Singh, Mahendra, Kirtipal, Nikhil, Kang, Sang Gu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873863/
https://www.ncbi.nlm.nih.gov/pubmed/33585567
http://dx.doi.org/10.3389/fmolb.2020.627842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873863/
https://www.ncbi.nlm.nih.gov/pubmed/33585567
http://dx.doi.org/10.3389/fmolb.2020.627842

Ejemplares similares